Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Pediatrix Medical (MD)

Pediatrix Q3 EPS rises to $0.84 from $0.23; raises 2025 Adjusted EBITDA outlook

Mixed Impact 4 of 5 earnings Written later

Pediatrix Medical Group reported third-quarter 2025 net income of $71.7 million, or $0.84 per diluted share, up from $19.4 million, or $0.23, a year earlier. Net revenue fell to $492.9 million from $511.2 million, which the company attributed mainly to practice dispositions. The company raised its full-year 2025 Adjusted EBITDA outlook to a range of $270 million to $290 million.

Key points

  • Q3 2025 net revenue $492.9 million vs. $511.2 million a year earlier; same-unit net revenue grew 8.0 percent
  • Q3 2025 Adjusted EBITDA $87.3 million vs. $60.2 million; Adjusted EPS $0.67 vs. $0.44
  • Full-year 2025 Adjusted EBITDA now expected at $270 million to $290 million
  • Cash and cash equivalents $340.1 million at September 30, 2025; total debt $602 million

The filing

CompanyPediatrix Medical (MD)
Form8-K, current report
Filed with the SECNov 3, 2025, 6:50 AM ET
Accession number0001193125-25-261626

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.